Cor Vasa 2020, 62(Suppl. 1):11-14 | DOI: 10.33678/cor.2020.044

(Facts and thoughts on COVID-19 pandemic)

Petr Widimský
Kardiocentrum, 3. lékařská fakulta Univerzity Karlovy a Fakultní nemocnice Královské Vinohrady, Praha

COVID-19 disease surprised many countries and found their health care services unprepared for such acute pandemic. The large differences in case load and death rates between different states remain even after per capita calculation (e.g. New York State has 36× more COVID-19 deaths than the Czech Republic). This new pandemic will have indirect effects also on practice of cardiovascular medicine. Several drugs for COVID-19 treatment are currently tested in clinical trials, but so far none of them was shown to be really effective, disease modifying.

Keywords: Cardiovascular disease, COVID-19, Epidemic

Received: May 11, 2020; Accepted: May 12, 2020; Published: June 22, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Widimský P. (Facts and thoughts on COVID-19 pandemic). Cor Vasa. 2020;62(Suppl. 1):11-14. doi: 10.33678/cor.2020.044.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Cao B, Wang Y, Wen D, et al. A Trial of Lopinavir-Ritonavir in Adults Hospitalized With Severe Covid-19. N Engl J Med 2020;382:1787-1799. Go to original source... Go to PubMed...
    2. Grein J, Ohmagari N, Shin D, et al. Compassionate Use of Remdesivir for Patients with Severe Covid-19 [published online ahead of print, 2020 Apr 10]. N Engl J Med 2020;NEJMoa2007016. doi: 10.1056/NEJMoa2007016. Go to original source... Go to PubMed...
    3. Multicenter collaboration group of Department of Science and Technology of Guangdong Province and Health Commission of Guangdong Province for chloroquine in the treatment of novel coronavirus pneumonia. Zhonghua Jie He He Hu Xi Za Zhi 2020;43:185-188. Go to PubMed...
    4. Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open--label non-randomized clinical trial [published online ahead of print, 2020 Mar 20]. Int J Antimicrob Agents 2020;105949. doi: 10.1016/j.ijantimicag.2020.105949. Go to original source... Go to PubMed...
    5. Shen C, Wang Z, Zhao F, et al. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma [published online ahead of print, 2020 Mar 27]. JAMA 2020;323: 1582-1589.

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes